Characterization of the viral O-glycopeptidome: A novel tool of: Relevance for vaccine design and serodiagnosis

Journal of Virology

Volumn 86, Issue 11, 2012, Pages 6268-6278

  Cló, Emiliano ^a   Kračun, Stjepan K ^a   Nudelman, Aaron S ^a   Jensen, Knud J ^a   Liljeqvist, Jan Ake ^b   Olofsson, Sigvard ^b   Bergström, Tomas ^b   Blixt, Ola ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; LECTIN; PROLINE; SERINE; THREONINE; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; POLYSACCHARIDE; VACCINE; VIRUS ENVELOPE PROTEIN;

ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; EPITOPE MAPPING; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; RECURRENT INFECTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS IMMUNITY; BIOLOGY; CHEMISTRY; GENETICS; IMMUNOLOGY; METHODOLOGY; SEROLOGY;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

COMPUTATIONAL BIOLOGY; EPITOPES; GLYCOPROTEINS; HERPESVIRUS 2, HUMAN; HUMANS; POLYSACCHARIDES; SEROLOGIC TESTS; VACCINES; VIRAL ENVELOPE PROTEINS;

EID: 84863600673     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00392-12     Document Type: Article

References (42)

1. Ashley-Morrow R, Krantz E, Wald A. 2003. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex. Transm. Dis. 30:310-314.
2. Bennett EP, et al. Control of mucin-type O-glycosylation-a classification of the polypeptide GalNAc-transferase gene family. Glycobiology, in press.
3. Bergstrom T, et al. 1990. Primary and recurrent herpes simplex virus type 2-induced meningitis. J. Infect. Dis. 162:322-330.
4. Blixt O, et al. 2011. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Res. 13:R25.
5. Blixt O, et al. 2010. A high-throughput O-glycopeptide discovery platform for seromic profiling. J. Proteome Res. 9:5250-5261.
6. Blixt O, et al. 2004. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. U. S. A. 101:17033-17038.
7. Blixt O, Norberg T. 1998. Solid-phase enzymatic synthesis of a sialyl Lewis X tetrasaccharide on a Sepharose matrix. J. Org. Chem. 63:2705-2710.
8. Blixt O, Razi N. 2006. Chemoenzymatic synthesis of glycan libraries. Methods Enzymol. 415:137-153.
9. Bolmstedt A, et al. 1996. Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12:213-220.
10. Brocke C, Kunz H. 2002. Synthesis of tumor-associated glycopeptide antigens. Bioorg. Med. Chem. 10:3085-3112.
11. Cohen J. 2010. Immunology. Painful failure of promising genital herpes vaccine. Science 330:304.
12. Collins PL, Mottet G. 1992. Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A. J. Gen. Virol. 73(Part 4):849-863.
13. Dall'Olio F, Malagolini N, Campadelli-Fiume G, Serafini-Cessi F. 1987. Glycosylation pattern of herpes simplex virus type 2 glycoprotein G from precursor species to the mature form. Arch. Virol. 97:237-249.
14. Falkowska E, Kajumo F, Garcia E, Reinus J, Dragic T. 2007. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. J. Virol. 81:8072-8079.
15. Gerken TA, et al. 2011. Emerging paradigms for the initiation of mucintype protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. J. Biol. Chem. 286:14493-14507.
16. Gill DJ, Clausen H, Bard F. 2011. Location, location, location: new insights into O-GalNAc protein glycosylation. Trends Cell Biol. 21:149-158.
17. Hansen JE, et al. 1996. Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop. Arch. Virol. 141:291-300.
18. Johnston C, Koelle DM, Wald A. 2011. HSV-2: in pursuit of a vaccine. J. Clin. Invest. 121:4600-4609.
19. Julenius K, Molgaard A, Gupta R, Brunak S. 2005. Prediction, conser-vation analysis, and structural characterization of mammalian mucintype O-glycosylation sites. Glycobiology 15:153-164.
20. Kalantari-Dehaghi M, et al. 2012. Discovery of potential diagnostic and vaccine antigens in herpes simplex virus-1 and -2 by proteome-wide antibody profiling. J. Virol. 86:4328-4339.
21. Kracun SK, et al. 2010. Random glycopeptide bead libraries for seromic biomarker discovery. J. Proteome Res. 9:6705-6714.
22. Kurt-Jones EA, et al. 2004. Herpes simplex virus 1 interaction with Tolllike receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 101:1315-1320.
23. Lee JE, Saphire EO. 2009. Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. Curr. Opin. Struct. Biol. 19:408-417.
24. Leppanen A, Penttila L, Renkonen O, McEver RP, Cummings RD. 2002. Glycosulfopeptides with O-glycans containing sialylated and polyfucosylated polylactosamine bind with low affinity to P-selectin. J. Biol. Chem. 277:39749-39759.
25. Levi M, Rudén U, Wahren B. 1996. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin. Diagn. Lab. Immunol. 3:265-269.
26. Liljeqvist JA, et al. 1998. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J. Gen. Virol. 79(Part 5):1215-1224.
27. Marsden H, MacAulay K, Murray J, Smith I. 1998. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J. Med. Virol. 56:79-84.
28. Meldal M, Svendsen I, Breddam K, Auzanneau FI. 1994. Portionmixing peptide libraries of quenched fluorogenic substrates for complete subsite mapping of endoprotease specificity. Proc. Natl. Acad. Sci. U. S. A. 91:3314-3318.
29. Miller SD, et al. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-1136.
30. Nystrom K, et al. 2007. Virus-induced transcriptional activation of host FUT genes associated with neo-expression of Ley in cytomegalovirusinfected and sialyl-Lex in varicella-zoster virus-infected diploid human cells. Glycobiology 17:355-366.
31. Ohyabu N, et al. 2009. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library. J. Am. Chem. Soc. 131:17102-17109.
32. Olofsson S, Hansen JE. 1998. Host cell glycosylation of viral glycoproteins- a battlefield for host defence and viral resistance. Scand. J. Infect. Dis. 30:435-440.
33. Olofsson S, Lundström M, Marsden H, Jeansson S, Vahlne A. 1986. Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG. J. Gen. Virol. 67(Part 4):737-744.
34. Sorensen AL, et al. 2006. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. Glycobiology 16:96-107.
35. Stansell E, Canis K, Haslam SM, Dell A, Desrosiers RC. 2011. Simian immunodeficiency virus from the sooty mangabey and rhesus macaque is modified with O-linked carbohydrate. J. Virol. 85:582-595.
36. Sugrue RJ. 2007. Viruses and glycosylation: an overview. Methods Mol. Biol. 379:1-13.
37. Svennerholm B, Olofsson S, Jeansson S, Vahlne A, Lycke E. 1984. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J. Clin. Microbiol. 19:235-239.
38. Tarp MA, et al. 2007. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat. Glycobiology 17:197-209.
39. Vigerust DJ, Shepherd VL. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 15:211-218.
40. Vohra Y, Buskas T, Boons GJ. 2009. Rapid assembly of oligosaccharides: a highly convergent strategy for the assembly of a glycosylated amino acid derived from PSGL-1. J. Org. Chem. 74:6064-6071.
41. Wahrenbrock MG, Varki A. 2006. Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg" ? Cancer Res. 66:2433-2441.
42. Wandall HH, et al. 2010. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 70:1306-1313.